157 related articles for article (PubMed ID: 37488397)
1. The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with highest mediastinal lymph node metastasis in non-small cell lung cancer.
Guo J; Zhang L; Zhang L; Wu J; Xu L; E H; Li C; Wu H; Zhao D; Hu Y; Zhang J; Hu X
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13311-13321. PubMed ID: 37488397
[TBL] [Abstract][Full Text] [Related]
2. The addition of radiotherapy to adjuvant chemotherapy has a combinatorial effect in pN2 non-small cell lung cancer only with extranodal invasion or multiple N2 metastasis.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Park SI; Kim DK
Lung Cancer; 2021 May; 155():94-102. PubMed ID: 33765654
[TBL] [Abstract][Full Text] [Related]
3. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer.
Yun JK; Bok JS; Lee GD; Kim HR; Kim YH; Kim DK; Park SI; Choi S
Eur J Cardiothorac Surg; 2020 Jul; 58(1):59-69. PubMed ID: 32155245
[TBL] [Abstract][Full Text] [Related]
6. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
7. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
Wu XW; Chen T; Yin S; Deng Y; Zhao B
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344
[No Abstract] [Full Text] [Related]
8. Uncertain resection of highest mediastinal lymph node positive among pN2 non-small cell lung cancer patients: survival analysis of postoperative radiotherapy and driver gene mutations.
Deng Q; Wang H; Xiu W; Tian X; Gong Y
Jpn J Radiol; 2023 May; 41(5):551-560. PubMed ID: 36484979
[TBL] [Abstract][Full Text] [Related]
9. Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.
Xu Y; Li J; Wang J; Hu X; Ma H; Li P; Zheng X; Chen M
Oncol Lett; 2018 Feb; 15(2):2641-2650. PubMed ID: 29434986
[TBL] [Abstract][Full Text] [Related]
10. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
Wang S; Zhou W; Zhang H; Zhao M; Chen X
Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
[TBL] [Abstract][Full Text] [Related]
11. Survival outcome of upfront surgery for clinical single-station N2 non-small cell lung cancer.
Hayakawa T; Isaka M; Konno H; Mizuno T; Kawata T; Kenmotsu H; Takahashi T; Ohde Y
Jpn J Clin Oncol; 2023 Apr; 53(5):429-435. PubMed ID: 36655315
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Patients with Stage III-N2 Non-small Cell Lung Cancer.
Liu J; Shi Z; Cao B; Wang Z; Zhang N; Liu J
Ann Surg Oncol; 2024 Mar; ():. PubMed ID: 38520577
[TBL] [Abstract][Full Text] [Related]
13. Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins.
Yuan M; Men Y; Kang J; Sun X; Zhao M; Bao Y; Yang X; Sun S; Ma Z; Wang J; Deng L; Wang W; Zhai Y; Liu W; Zhang T; Wang X; Bi N; Lv J; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Wang L; Hui Z
Thorac Cancer; 2021 Jan; 12(2):227-234. PubMed ID: 33247556
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Node-Spreading Pattern in Surgically Treated Small-Cell Lung Cancer: A Multicentric Analysis.
Leuzzi G; Lococo F; Alessandrini G; Sperduti I; Spaggiari L; Venuta F; Rendina EA; Granone PM; Rapicetta C; Zannini P; Di Rienzo G; Nicolosi M; Facciolo F
Lung; 2017 Feb; 195(1):107-114. PubMed ID: 27738827
[TBL] [Abstract][Full Text] [Related]
15. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
[TBL] [Abstract][Full Text] [Related]
16. Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis.
Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F
Clin Lung Cancer; 2020 Sep; 21(5):464-471.e1. PubMed ID: 32389508
[TBL] [Abstract][Full Text] [Related]
17. Significant prognostic factors for completely resected pN2 non-small cell lung cancer without neoadjuvant therapy.
Uehara H; Nakao M; Mun M; Nakagawa K; Nishio M; Ishikawa Y; Okumura S
Ann Thorac Cardiovasc Surg; 2015; 21(4):345-53. PubMed ID: 25740454
[TBL] [Abstract][Full Text] [Related]
18. A Validation Study of the Recommended Change in Residual Tumor Descriptors Proposed by the International Association for the Study of Lung Cancer for Patients With pN2 NSCLC.
Yun JK; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
J Thorac Oncol; 2021 May; 16(5):817-826. PubMed ID: 33607310
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic outcomes associated with lymph node examination status in early-stage non-small cell lung cancer: a real-world US study using the SEER-Medicare linked database.
Lee JM; To TM; Wang S; Lin CW; Johnson A; Meyer CS; Lee JS
Transl Cancer Res; 2024 Apr; 13(4):1821-1833. PubMed ID: 38737679
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Clinicopathological Factors to Guide Post-Operative Radiotherapy in Completely Resected pN2-Stage III Non-Small Cell Lung Cancer.
Chien JC; Hu YC; Tsai YJ; Chien YT; Feng IJ; Shiue YL
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
